Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVERS: Ceftaroline Fosamil vs Vancomycin + Aztreonam in cSSTI
NCT01499277Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 28
01
Overview
A Phase 3 trial of ceftaroline fosamil in skin and soft tissue infection (SSTI), sponsored by Pfizer. Started May 2012; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
skin and soft tissue infection (SSTI)
Beyond the preview
Go deeper on NCT01499277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01499277.